Literature DB >> 1770167

Ontogeny of steroid accumulation in spinal lumbar motoneurons of the rat: implications for androgen's site of action during synapse elimination.

C L Jordan1, S M Breedlove, A P Arnold.   

Abstract

Androgens influence the postnatal development of motoneurons in the spinal nucleus of the bulbocavernosus (SNB) by regulating neuromuscular synapse elimination, the process through which multiple axonal inputs are retracted from each muscle fiber until single innervation is established. In the rat levator ani (LA), one of the target muscles for SNB motoneurons, much of this loss of multiple innervation can be prevented by prepubertal androgen treatment. We used steroid autoradiography to measure the ontogeny of steroid accumulation in the SNB and the retrodorsolateral nucleus (RDLN), two motoneuronal groups thought to differ in their sensitivity to androgens. Spinal cord tissue was analyzed from castrated male rats at 7, 14, 21, and 60 days of age after injection of radiolabelled testosterone. SNB and RDLN motoneurons differ in the ontogeny of androgen accumulation. Over 80% of SNB motoneurons develop the capacity to accumulate androgen during the second week after birth, during the period when androgen regulates synapse elimination in the LA. In contrast, androgen accumulation in RDLN motoneurons develops much later (after 21 days). These data suggest that androgen may act directly on SNB motoneurons to influence synapse elimination.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1770167     DOI: 10.1002/cne.903130304

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  10 in total

Review 1.  Cellular and molecular mechanisms of sexual differentiation in the mammalian nervous system.

Authors:  Nancy G Forger; J Alex Strahan; Alexandra Castillo-Ruiz
Journal:  Front Neuroendocrinol       Date:  2016-01-11       Impact factor: 8.606

Review 2.  The spinal nucleus of the bulbocavernosus: firsts in androgen-dependent neural sex differences.

Authors:  Dale R Sengelaub; Nancy G Forger
Journal:  Horm Behav       Date:  2007-11-28       Impact factor: 3.587

3.  Sexual differentiation of the nervous system: where the action is.

Authors:  M L Seney; N G Forger
Journal:  Endocrinology       Date:  2009-07       Impact factor: 4.736

4.  Neuronal size in the spinal nucleus of the bulbocavernosus: direct modulation by androgen in rats with mosaic androgen insensitivity.

Authors:  N V Watson; L M Freeman; S M Breedlove
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

Review 5.  Insight into the neuroendocrine basis of signal evolution: a case study in foot-flagging frogs.

Authors:  Lisa A Mangiamele; Matthew J Fuxjager
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2017-10-07       Impact factor: 1.836

6.  Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model.

Authors:  Zhigang Yu; Nahid Dadgar; Megan Albertelli; Kirsten Gruis; Cynthia Jordan; Diane M Robins; Andrew P Lieberman
Journal:  J Clin Invest       Date:  2006-09-14       Impact factor: 14.808

Review 7.  Androgen receptors and muscle: a key mechanism underlying life history trade-offs.

Authors:  D Ashley Monks; Melissa M Holmes
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2017-10-23       Impact factor: 1.836

8.  Neonatal androgen and estrogen treatments masculinize the size of motoneurons in the rat spinal nucleus of the bulbocavernosus.

Authors:  S M Breedlove
Journal:  Cell Mol Neurobiol       Date:  1997-12       Impact factor: 5.046

Review 9.  The organizational hypothesis and final common pathways: Sexual differentiation of the spinal cord and peripheral nervous system.

Authors:  Nancy G Forger
Journal:  Horm Behav       Date:  2009-05       Impact factor: 3.587

Review 10.  Neuroprotective actions of androgens on motoneurons.

Authors:  Keith N Fargo; Eileen M Foecking; Kathryn J Jones; Dale R Sengelaub
Journal:  Front Neuroendocrinol       Date:  2009-04-23       Impact factor: 8.606

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.